Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disorders
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disorders
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL ALLERGY
Volume 44, Issue 7, Pages 914-920
Publisher
Wiley
Online
2014-04-05
DOI
10.1111/cea.12318
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mast cell activation syndromes: definition and classification
- (2013) P. Valent ALLERGY
- High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience
- (2013) T. Gülen et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Expanding Spectrum of Mast Cell Activation Disorders: Monoclonal and Idiopathic Mast Cell Activation Syndromes
- (2013) Matthieu Picard et al. CLINICAL THERAPEUTICS
- Higher mast cell load decreases the risk of Hymenoptera venom–induced anaphylaxis in patients with mastocytosis
- (2013) Bjorn van Anrooij et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM
- (2013) Iván Álvarez-Twose et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Familial Occurrence of Systemic Mast Cell Activation Disease
- (2013) Gerhard J. Molderings et al. PLoS One
- Comparative analysis of IL6 and IL6 receptor gene polymorphisms in mastocytosis
- (2012) Eszter Rausz et al. BRITISH JOURNAL OF HAEMATOLOGY
- Mast Cell Activation Syndrome: A Review
- (2012) Marianne Frieri et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Systemic mastocytosis as a risk factor for severe Hymenoptera sting–induced anaphylaxis
- (2012) Iván Alvarez-Twose et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases
- (2011) Gerhard J. Molderings et al. INTERNAL MEDICINE
- Severe Life-Threatening or Disabling Anaphylaxis in Patients with Systemic Mastocytosis: A Single-Center Experience
- (2011) Friedrich Wimazal et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal
- (2011) Peter Valent et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Validation of the REMA Score for Predicting Mast Cell Clonality and Systemic Mastocytosis in Patients with Systemic Mast Cell Activation Symptoms
- (2011) I. Alvarez-Twose et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Tyrosine kinase inhibitors in the treatment of systemic mastocytosis
- (2011) Celalettin Ustun et al. LEUKEMIA RESEARCH
- Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients
- (2010) K. Brockow et al. ALLERGY
- Gene expression analysis predicts insect venom anaphylaxis in indolent systemic mastocytosis
- (2010) M. Niedoszytko et al. ALLERGY
- Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a study
- (2010) Carle Paul et al. AMERICAN JOURNAL OF HEMATOLOGY
- Anaphylaxis and Mast Cell Disease: What Is the Risk?
- (2010) Cem Akin CURRENT ALLERGY AND ASTHMA REPORTS
- Mastocytosis and insect venom allergy
- (2010) Patrizia Bonadonna et al. Current Opinion in Allergy and Clinical Immunology
- In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V
- (2010) Alexandra Böhm et al. EXPERIMENTAL HEMATOLOGY
- Mast cell activation syndrome: Proposed diagnostic criteria
- (2010) Cem Akin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives
- (2010) Michel Arock et al. Expert Review of Hematology
- Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy
- (2009) M. Niedoszytko et al. ALLERGY
- Midostaurin (PKC412) inhibits immunoglobulin E-dependent activation and mediator release in human blood basophils and mast cells
- (2009) M.-T. Krauth et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Assessing anaphylactic risk? Consider mast cell clonality
- (2009) Dean D. Metcalfe et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels
- (2009) Patrizia Bonadonna et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations
- (2009) Christine Bodemer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Phase II Study of Dasatinib in Philadelphia Chromosome-Negative Acute and Chronic Myeloid Diseases, Including Systemic Mastocytosis
- (2008) S. Verstovsek et al. CLINICAL CANCER RESEARCH
- Prevention of Mast Cell Activation Disorder-Associated Clinical Sequelae of Excessive Prostaglandin D2 Production
- (2008) Joseph H. Butterfield et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis
- (2008) David González de Olano et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation